Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

BackgroundThe use of 5-hydroxytryptamine-3 receptor antagonists (5HT3RA) has long been considered the standard regimen for preventing chemotherapy-induced nausea and vomiting (CINV) prior to hematopoietic stem cell transplantation (HSCT). However, their therapeutic outcomes have been unsatisfactory....

Full description

Bibliographic Details
Main Authors: Hang Zhang, Qiang Zeng, Tian Dong, Xinchuan Chen, Pu Kuang, Jian Li, Qiuhui Wu, Ting Liu, Ting Niu, Zhigang Liu, Jie Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
chemotherapy-induced nausea and vomiting
netupitant/palonosetron
hematopoietic stem cell transplantation
5-hydroxytryptamine-3 receptor antagonist
neurokinin-1 receptor antagonist
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1280336/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1280336/full

Similar Items